Diamond Therapeutics

Diamond Therapeutics is led by a team of scientists and clinicians who are developing treatments for illnesses and disorders of the central nervous system. The company is developing safe, EMA, FDA, and Health Canada-approved therapies for neuropsychiatric conditions, especially sub-perceptual psilocybin-based medicines that can potentially deliver a larger impact than the current treatments and first-line methods.

Diamond Therapeutics

The company is building upon its vast experince to bring well-tolerated interventions for a wide variety of patient groups in order to maximize the positive impact of drugs and bridge gaps in global mental healthcare.

“Revolutionizing the treatment of mental health.”